Holen Sie sich die Stockscreener-App
56.56
1.13%
0.63
Schlusskurs vom Vortag:
$55.93
Offen:
$55.98
24-Stunden-Volumen:
20,757
Relative Volume:
0.38
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.57%
1M Leistung:
+14.87%
6M Leistung:
+33.27%
1J Leistung:
+24.80%
1-Tages-Spanne:
$55.91
$56.69
1-Wochen-Bereich:
$53.81
$57.24
52-Wochen-Spanne:
$35.22
$57.24
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
State Street Spdr S P Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
56.56 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.73 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
687.57 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
690.92 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.38 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
627.61 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
3 Undervalued ETFs to Buy Before 2026 - TradingView
Should you invest in the First Trust Health Care AlphaDEX ETF (FXH)? - MSN
Pharma ETF (XPH) hits a new 52-week high - MSN
Pfizer partners with YaoPharma to develop weight management drug - MSN
Pharma ETF (XPH) Hits a New 52-Week High - Zacks Investment Research
Should You Invest in the State Street SPDR S&P Software & Services ETF (XSW)? - Yahoo Finance
Is State Street SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? - Yahoo Finance
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
State Street SPDR S&P 1500 Momentum Tilt ETF Holdings - Quiver Quantitative
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
Best-Performing ETFs of November - TradingView
Should State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar? - Yahoo Finance
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
SPYM: S&P 500 Monthly Dashboard For December - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - MSN
Should State Street SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar? - sharewise.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Here's How Many Shares of the SPDR S&P Dividend ETF (SDY) You'd Need for $500 in Yearly Dividends - AOL.com
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) Be on Your Investing Radar? - Yahoo Finance
How Is Eli Lilly’s Stock Performance Compared to Other Pharmaceuticals? - inkl
Small Caps, Pharma Surge, While Nvidia, AMD TumbleState Street Health Care Select Sector SPDR ETF (ARCA:XLV) - Benzinga
State Street SPDR S&P Pharmaceuticals ETF Holdings - Quiver Quantitative
Best-Performing ETFs of Last Week: Healthcare Rules - TradingView
Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar? - Yahoo Finance
State Street SPDR S&P 1500 Value Tilt ETF Holdings - Quiver Quantitative
Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN
LVLNState Street SPDR S&P Leveraged Loan ETF Stock Price and Quote - Finviz
LVLN ETF Holdings List — AMEX:LVLN - TradingView
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Biopharmaceutical stocks performed strongly against the market trend, bolstered by industry mergers and acquisitions as well as favorable policy developments. - 富途牛牛
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Traders Eye Nvidia Earnings And Fed Minutes In A Busy Morning - Finimize
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MSN
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
M&A Injects Life Into Biotech Trade - TheStreet Pro
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - sharewise.com
SLYV: Unconvincing Small Cap ETF (NYSEARCA:SLYV) - Seeking Alpha
META_TITLE_SECTORS - Yahoo Finance
Short bets on S&P 500 Healthcare sector rises to 2.00% in October; MRNA stays most shorted stock - Seeking Alpha
SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Finanzdaten der State Street Spdr S P Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für State Street Spdr S P Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):